Videos Library
Understand the real drivers of HTA decision-making in oncology: What clinical and economic factors influence positive vs negative recommendations?
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR, Oncology
Overview
- How do payers evaluate products in an increasingly crowded marketplace.
- How successful are companies in getting new products approved?
- Comparing major payers: Where are similarities and where are the difference in their evaluations?
- Do companion diagnostics make a difference in the approval success rate?
Speaker
Anke van Engen
Principal, Advisory Services, Quintiles, Netherlands
Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.
Sponsor
